Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) EBITDA (2023 - 2025)

Ceribell's EBITDA history spans 3 years, with the latest figure at -$13.5 million for Q4 2025.

  • For Q4 2025, EBITDA fell 7.4% year-over-year to -$13.5 million; the TTM value through Dec 2025 reached -$53.3 million, down 31.64%, while the annual FY2025 figure was -$53.3 million, 31.64% down from the prior year.
  • EBITDA reached -$13.5 million in Q4 2025 per CBLL's latest filing, down from -$13.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$7.2 million in Q3 2023 to a low of -$13.6 million in Q2 2025.
  • Average EBITDA over 3 years is -$10.9 million, with a median of -$11.5 million recorded in 2024.
  • The largest YoY upside for EBITDA was 7.4% in 2025 against a maximum downside of 52.47% in 2025.
  • A 3-year view of EBITDA shows it stood at -$8.4 million in 2023, then crashed by 50.05% to -$12.6 million in 2024, then dropped by 7.4% to -$13.5 million in 2025.
  • Per Business Quant, the three most recent readings for CBLL's EBITDA are -$13.5 million (Q4 2025), -$13.3 million (Q3 2025), and -$13.6 million (Q2 2025).